Source:http://linkedlifedata.com/resource/pubmed/id/15188160
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2004-6-9
|
pubmed:abstractText |
Several randomized population-based studies have shown that screening for colorectal cancer (CRC) by fecal occult blood tests (FOBTs) can reduce CRC mortality. The aim of this French population-based study was to assess whether a similar benefit could be obtained in countries characterized by high performances in the diagnosis and management of CRC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0016-5085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1674-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15188160-Aged,
pubmed-meshheading:15188160-Colorectal Neoplasms,
pubmed-meshheading:15188160-Feces,
pubmed-meshheading:15188160-Female,
pubmed-meshheading:15188160-France,
pubmed-meshheading:15188160-Humans,
pubmed-meshheading:15188160-Incidence,
pubmed-meshheading:15188160-Male,
pubmed-meshheading:15188160-Mass Screening,
pubmed-meshheading:15188160-Middle Aged,
pubmed-meshheading:15188160-Occult Blood,
pubmed-meshheading:15188160-Survival Rate
|
pubmed:year |
2004
|
pubmed:articleTitle |
Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.
|
pubmed:affiliation |
Burgundy Cancer Registry, INSERM EPI 0106, Faculté de Médecine, BP 87900, 21079 Dijon CEDEX, France. jean.faivre@u-bourgogne.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|